BIIB Financial Facts
Total revenues: 1.42BResearch and development: 345.18M
See Full Income Statement
Accounts payable: -285.91M
Cash and cash equivalents: 570.72M
See Full Balance Sheet
Earnings History for Biogen Idec Inc. (BIIB)
|
Expand Research on BIIB
| Next EPS Date | 7/23/13 *Est. | EPS Growth Rate | +40.7% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +13.4% | Revenue Growth Rate | +8.5% *Last Qtr. |
| Average % Move 1-Wk after EPS | +3.7% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/13  |
 |
Q113 | $1.97 | $1.63 | +$0.34 | $1.4B | $1.41B | N/A / N/A | = | +1% | Details |
| 1/28/13 |
|
Q412 | $1.40 | $1.46 | -$0.06 | $1.4B | $1.38B | N/A / N/A | = | +42.4% | Details |
| 10/25/12 |
|
Q312 | $1.91 | $1.59 | +$0.32 | $1.39B | $1.38B | $1.64 / $1.4B | = | +46.6% | Details |
| 7/24/12 |
|
Q212 | $1.82 | $1.56 | +$0.26 | $1.4B | $1.33B | N/A / N/A | = | +49.6% | Details |
| 5/1/12 |
|
Q112 | $1.40 | $1.48 | -$0.08 | $1.29B | $1.31B | N/A / N/A | = | +55.4% | Details |
| 1/31/12 |
|
Q411 | $1.51 | $1.49 | +$0.02 | $1.3B | $1.29B | N/A / N/A | = | +78.6% | Details |
| 10/28/11 |
|
Q311 | $1.61 | $1.53 | +$0.08 | $1.31B | $1.27B | $1.42 / $1.32B | = | +76.9% | Details |
| 7/26/11 |
|
Q211 | $1.36 | $1.37 | -$0.01 | $1.21B | $1.18B | N/A / N/A | = | +100.3% | Details |
